Profil
Douglas Reynolds is the founder and current President of KYE Pharmaceuticals, Inc. which is founded in 2019.
He previously worked as a Director at Cynapsus Therapeutics, Inc. and as President at Sunovion Pharmaceuticals Canada, Inc.
Aktive Positionen von Douglas Reynolds
| Unternehmen | Position | Beginn |
|---|---|---|
KYE Pharmaceuticals, Inc.
 KYE Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KYE Pharmaceuticals, Inc. manufactures pharmaceuticals. The private company is based in Mississauga, Canada. The Canadian company was founded in 2019 by Douglas Reynolds, Eryn Corriveau. | Gründer | 01.01.2019 |
Ehemalige bekannte Positionen von Douglas Reynolds
| Unternehmen | Position | Ende |
|---|---|---|
Sunovion Pharmaceuticals Canada, Inc.
 Sunovion Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Canada, Inc. engages in the development and commercialization of prescription products in Canada. The firm focuses of cardiology, central nervous system, and infectious disease. The company was founded in 2010 and is headquartered in Mississauga, Canada. | Präsident | - |
| CYNAPSUS THERAPEUTICS INC | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Sunovion Pharmaceuticals Canada, Inc.
Sunovion Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Canada, Inc. engages in the development and commercialization of prescription products in Canada. The firm focuses of cardiology, central nervous system, and infectious disease. The company was founded in 2010 and is headquartered in Mississauga, Canada. | Health Technology |
KYE Pharmaceuticals, Inc.
KYE Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KYE Pharmaceuticals, Inc. manufactures pharmaceuticals. The private company is based in Mississauga, Canada. The Canadian company was founded in 2019 by Douglas Reynolds, Eryn Corriveau. | Health Technology |
